United States Fragmin Market Report 2016

October 2016 | 116 pages | ID: U8DD08D0157EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Fragmin

Revenue, means the sales value of Fragmin

This report studies sales (consumption) of Fragmin in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Pfizer, Inc. (US)
• Bayer Healthcare AG (Germany)
• GlaxoSmithKline Plc. (UK)
• Boehringer Ingelheim (Germany)
• Sanofi S.A. (France)
• Abbott India Limited (India)
• Aspen Holdings (South Africa)
• Bristol-Myers Squibb Company (US)
• Eisai Inc. (US)
• Mitsubishi Tanabe Pharma Corporation (Japan)
• Teva Pharmaceutical Industries Ltd. (Israel)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Fragmin in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Fragmin Market Report 2016

1 FRAGMIN OVERVIEW

1.1 Product Overview and Scope of Fragmin
1.2 Classification of Fragmin
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Fragmin
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Fragmin (2011-2021)
  1.4.1 United States Fragmin Sales and Growth Rate (2011-2021)
  1.4.2 United States Fragmin Revenue and Growth Rate (2011-2021)

2 UNITED STATES FRAGMIN COMPETITION BY MANUFACTURERS

2.1 United States Fragmin Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Fragmin Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Fragmin Average Price by Manufactures (2015 and 2016)
2.4 Fragmin Market Competitive Situation and Trends
  2.4.1 Fragmin Market Concentration Rate
  2.4.2 Fragmin Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES FRAGMIN SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Fragmin Sales and Market Share by Type (2011-2016)
3.2 United States Fragmin Revenue and Market Share by Type (2011-2016)
3.3 United States Fragmin Price by Type (2011-2016)
3.4 United States Fragmin Sales Growth Rate by Type (2011-2016)

4 UNITED STATES FRAGMIN SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Fragmin Sales and Market Share by Application (2011-2016)
4.2 United States Fragmin Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES FRAGMIN MANUFACTURERS PROFILES/ANALYSIS

5.1 Pfizer, Inc. (US)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Fragmin Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Pfizer, Inc. (US) Fragmin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Bayer Healthcare AG (Germany)
  5.2.2 Fragmin Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Bayer Healthcare AG (Germany) Fragmin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 GlaxoSmithKline Plc. (UK)
  5.3.2 Fragmin Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 GlaxoSmithKline Plc. (UK) Fragmin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Boehringer Ingelheim (Germany)
  5.4.2 Fragmin Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Boehringer Ingelheim (Germany) Fragmin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Sanofi S.A. (France)
  5.5.2 Fragmin Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Sanofi S.A. (France) Fragmin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Abbott India Limited (India)
  5.6.2 Fragmin Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Abbott India Limited (India) Fragmin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Aspen Holdings (South Africa)
  5.7.2 Fragmin Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Aspen Holdings (South Africa) Fragmin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Bristol-Myers Squibb Company (US)
  5.8.2 Fragmin Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Bristol-Myers Squibb Company (US) Fragmin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Eisai Inc. (US)
  5.9.2 Fragmin Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Eisai Inc. (US) Fragmin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Mitsubishi Tanabe Pharma Corporation (Japan)
  5.10.2 Fragmin Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Mitsubishi Tanabe Pharma Corporation (Japan) Fragmin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Teva Pharmaceutical Industries Ltd. (Israel)

6 FRAGMIN MANUFACTURING COST ANALYSIS

6.1 Fragmin Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Fragmin

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Fragmin Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Fragmin Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES FRAGMIN MARKET FORECAST (2016-2021)

10.1 United States Fragmin Sales, Revenue Forecast (2016-2021)
10.2 United States Fragmin Sales Forecast by Type (2016-2021)
10.3 United States Fragmin Sales Forecast by Application (2016-2021)
10.4 Fragmin Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Fragmin
Table Classification of Fragmin
Figure United States Sales Market Share of Fragmin by Type in 2015
Table Application of Fragmin
Figure United States Sales Market Share of Fragmin by Application in 2015
Figure United States Fragmin Sales and Growth Rate (2011-2021)
Figure United States Fragmin Revenue and Growth Rate (2011-2021)
Table United States Fragmin Sales of Key Manufacturers (2015 and 2016)
Table United States Fragmin Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Fragmin Sales Share by Manufacturers
Figure 2016 Fragmin Sales Share by Manufacturers
Table United States Fragmin Revenue by Manufacturers (2015 and 2016)
Table United States Fragmin Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Fragmin Revenue Share by Manufacturers
Table 2016 United States Fragmin Revenue Share by Manufacturers
Table United States Market Fragmin Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Fragmin Average Price of Key Manufacturers in 2015
Figure Fragmin Market Share of Top 3 Manufacturers
Figure Fragmin Market Share of Top 5 Manufacturers
Table United States Fragmin Sales by Type (2011-2016)
Table United States Fragmin Sales Share by Type (2011-2016)
Figure United States Fragmin Sales Market Share by Type in 2015
Table United States Fragmin Revenue and Market Share by Type (2011-2016)
Table United States Fragmin Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Fragmin by Type (2011-2016)
Table United States Fragmin Price by Type (2011-2016)
Figure United States Fragmin Sales Growth Rate by Type (2011-2016)
Table United States Fragmin Sales by Application (2011-2016)
Table United States Fragmin Sales Market Share by Application (2011-2016)
Figure United States Fragmin Sales Market Share by Application in 2015
Table United States Fragmin Sales Growth Rate by Application (2011-2016)
Figure United States Fragmin Sales Growth Rate by Application (2011-2016)
Table Pfizer, Inc. (US) Basic Information List
Table Pfizer, Inc. (US) Fragmin Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer, Inc. (US) Fragmin Sales Market Share (2011-2016)
Table Bayer Healthcare AG (Germany) Basic Information List
Table Bayer Healthcare AG (Germany) Fragmin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Healthcare AG (Germany) Fragmin Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc. (UK) Basic Information List
Table GlaxoSmithKline Plc. (UK) Fragmin Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc. (UK) Fragmin Sales Market Share (2011-2016)
Table Boehringer Ingelheim (Germany) Basic Information List
Table Boehringer Ingelheim (Germany) Fragmin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim (Germany) Fragmin Sales Market Share (2011-2016)
Table Sanofi S.A. (France) Basic Information List
Table Sanofi S.A. (France) Fragmin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi S.A. (France) Fragmin Sales Market Share (2011-2016)
Table Abbott India Limited (India) Basic Information List
Table Abbott India Limited (India) Fragmin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott India Limited (India) Fragmin Sales Market Share (2011-2016)
Table Aspen Holdings (South Africa) Basic Information List
Table Aspen Holdings (South Africa) Fragmin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Aspen Holdings (South Africa) Fragmin Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Company (US) Basic Information List
Table Bristol-Myers Squibb Company (US) Fragmin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Company (US) Fragmin Sales Market Share (2011-2016)
Table Eisai Inc. (US) Basic Information List
Table Eisai Inc. (US) Fragmin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eisai Inc. (US) Fragmin Sales Market Share (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Basic Information List
Table Mitsubishi Tanabe Pharma Corporation (Japan) Fragmin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Fragmin Sales Market Share (2011-2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Basic Information List
Table Teva Pharmaceutical Industries Ltd. (Israel) Fragmin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Fragmin Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Fragmin
Figure Manufacturing Process Analysis of Fragmin
Figure Fragmin Industrial Chain Analysis
Table Raw Materials Sources of Fragmin Major Manufacturers in 2015
Table Major Buyers of Fragmin
Table Distributors/Traders List
Figure United States Fragmin Production and Growth Rate Forecast (2016-2021)
Figure United States Fragmin Revenue and Growth Rate Forecast (2016-2021)
Table United States Fragmin Production Forecast by Type (2016-2021)
Table United States Fragmin Consumption Forecast by Application (2016-2021)